Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals K Hesamizadeh, H Sharafi, MS Rezaee-Zavareh, B Behnava, SM Alavian Hepatitis Monthly 16 (4), 2016 | 83 | 2016 |
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis H Ghaderi-Zefrehi, M Gholami-Fesharaki, H Sharafi, F Sadeghi, ... Hepatitis Monthly 16 (9), 2016 | 77 | 2016 |
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline SM Alavian, B Hajarizadeh, KB Lankarani, H Sharafi, NE Daryani, S Merat, ... Hepatitis Monthly 16 (8), 2016 | 69 | 2016 |
Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of … H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ... Hepatitis monthly 12 (3), 190, 2012 | 54 | 2012 |
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran K Hesamizadeh, H Sharafi, H Keyvani, SM Alavian, ANT Shabankareh, ... Hepatitis Monthly 16 (1), 2016 | 42 | 2016 |
Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ... Hepatitis monthly 12 (12), 2012 | 39 | 2012 |
Association of-24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia MJ Sharifi, G Bahoush, F Zaker, S Ansari, KA Rafsanjani, H Sharafi Pediatric Hematology-Oncology 31 (2), 169-177, 2014 | 36 | 2014 |
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review SM Haghgoo, H Sharafi, SM Alavian Clinical Chemistry and Laboratory Medicine (CCLM), 2019 | 34 | 2019 |
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013 M Keshvari, H Sharafi, SM Alavian, H Mehrabadi, S Zolfaghari Transfusion and Apheresis Science 53 (1), 38-47, 2015 | 34 | 2015 |
Combination of Ledipasvir and Sofosbuvir for treatment of hepatitis C virus genotype 1 infection: systematic review and meta-analysis MS Rezaee-Zavareh, K Hesamizadeh, B Behnava, SM Alavian, ... Annals of hepatology 16 (2), 188-197, 2017 | 33 | 2017 |
Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers R Rashti, H Sharafi, SM Alavian, Y Moradi, A Mohamadi Bolbanabad, ... Pathogens 9 (6), 432, 2020 | 31 | 2020 |
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis F Dolatimehr, H Karimi-Sari, MS Rezaee-Zavareh, SM Alavian, ... DARU Journal of Pharmaceutical Sciences 25 (1), 11, 2017 | 30 | 2017 |
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis R Rashti, SM Alavian, Y Moradi, H Sharafi, A Mohamadi Bolbanabad, ... Archives of virology 165, 1947-1958, 2020 | 28 | 2020 |
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting H Sharafi, H Poustchi, F Azimian, B Tamadoni, R Ramezani, MM Gouya, ... Journal of Clinical Virology 113, 20-23, 2019 | 28 | 2019 |
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients A Haj-sheykholeslami, M Keshvari, H Sharafi, A Pouryasin, K Hemmati, ... World journal of gastroenterology: WJG 21 (29), 8935, 2015 | 28 | 2015 |
IL28B polymorphism, Explanation for Different Responses to Therapy in Hepatitis C Patients H Sharafi, SM Alavian Hepatitis Monthly 11 (12), 958, 2011 | 28 | 2011 |
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran G Moradi, B Hajarizadeh, K Rahmani, A Mohamadi-Bolbanabad, ... International Journal of Drug Policy 73, 129-134, 2019 | 27 | 2019 |
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study H Sharafi, SM Alavian, B Behnava, A Pouryasin, M Keshvari Hepatitis monthly 14 (10), 2014 | 27 | 2014 |
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era S Hariri, H Sharafi, M Sheikh, S Merat, F Hashemi, F Azimian, B Tamadoni, ... Harm Reduction Journal 17, 1-9, 2020 | 24 | 2020 |
The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017 H Sharafi, SM Alavian Clinical Liver Disease 14 (6), 219-223, 2019 | 24 | 2019 |